NPPA fixes prices of 27 essential formulations
New Delhi: National drug pricing regulator NPPA Thursday said it has notified prices of 27 essential formulations, including those used for the treatment of diabetes, blood pressure and pain.
"NPPA has fixed/revised ceiling prices/Retail Prices of 27 scheduled formulations under Drugs (Prices Control) Order, 2013," it said in a statement.
NPPA fixes ceiling price of essential medicines of Schedule I under the Drugs (Prices Control) Order (DPCO) 2013.
In respect of medicines that are not under price control, manufacturers are allowed to increase the maximum retail price by 10 percent annually.
The calculation of essential drugs is based on the simple average of all medicines in a particular therapeutic segment with sales of more than 1 percent.
Following are the details
| Sl. No. | Name of the Scheduled Formulation /Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Pre-GST) (Rs.) | Retail Price (Post-GST ) (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) | (7) |
| 1. | Voglibose + Metformin | Each tablet contains: Voglibose 0.2mg Metformin 500mg | 1 Tablet | M/s Lupin Ltd. | 4.84 | 4.64 |
| 2. | Voglibose + Metformin | Each tablet contains: Voglibose 0.3mg Metformin 500mg | 1 Tablet | M/s Lupin Ltd. | 5.76 | 5.52 |
| 3. | Voglibose + Metformin+ Glimepirid | Each tablet contains: Voglibose 0.2mg Metformin 500mg Glimepirid 1mg | 1 Tablet | M/s Lupin Ltd. | 7.14 | 6.85 |
| 4. | Voglibose + Metformin+ Glimepirid | Each tablet contains: Voglibose 0.2mg Metformin 500mg Glimepirid 1mg | 1 Tablet | M/s Sanofi India Ltd. | 7.14 | 6.85 |
| 5. | Voglibose + Metformin+ Glimepirid | Each tablet contains: Voglibose 0.2mg Metformin 500mg Glimepirid 1mg | 1 Tablet | M/s Biocon Ltd. | 7.14 | 6.85 |
| 6. | Voglibose + Metformin+ Glimepirid | Each tablet contains: Voglibose 0.2mg Metformin 500mg Glimepirid 2mg | 1 Tablet | M/s Lupin Ltd. | 9.05 | 8.68 |
| 7. | Voglibose + Metformin+ Glimepirid | Each tablet contains: Voglibose 0.2mg Metformin 500mg Glimepirid 2mg | 1 Tablet | M/s Sanofi India Ltd. | 9.05 | 8.68 |
| 8. | Voglibose + Metformin+ Glimepirid | Each tablet contains: Voglibose 0.2mg Metformin 500mg Glimepirid 2mg | 1 Tablet | M/s Biocon Ltd. | 9.05 | 8.68 |
| 9. | Voglibose + Metformin+ Glimepirid | Each tablet contains: Voglibose 0.3mg Metformin 500mg Glimepirid 1mg | 1 Tablet | M/s Lupin Ltd. | 8.52 | 8.17 |
| 10. | Voglibose + Metformin+ Glimepirid | Each tablet contains: Voglibose 0.3mg Metformin 500mg Glimepirid 1mg | 1 Tablet | M/s Alembic Ltd. | 8.52 | 8.17 |
| 11. | Voglibose + Metformin+ Glimepirid | Each tablet contains: Voglibose 0.3mg Metformin 500mg Glimepirid 2mg | 1 Tablet | M/s Lupin Ltd. | 10.46 | 10.03 |
| 12. | Diclofenac + Tramadol | Each tablet contains: Diclofenac 75mg Tramadol 50mg | 1 Tablet | M/s Alembic Ltd. | 9.73 | 9.33 |
| Sl. No. | Name of the Scheduled Formulation /Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Pre-GST) (Rs.) | Retail Price (Post-GST ) (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) | (7) |
| 1. | Glimepiride+ Metformin Tablets | Tablet Contains: Glimepiride 1mg & Metformin 500mg. | 1 Tablet | M/s Lupin Limited | 4.00 | 3.84 |
| 2. | Glimepiride + Metformin Tablets | Tablet Contains: Glimepiride 2mg & Metformin 500mg. | 1 Tablet | M/s Lupin Limited | 4.50 | 4.32 |
| 3. | Metoprolol + Chlorthalidone Tablets | Tablet Contains: Metoprolol 25mg & Chlorthalidone 12.5mg. | 1 Tablet | M/s Lupin Limited | 5.81 | 5.57 |
| 4. | Metoprolol+ Chlorthalidone Tablets | Tablet Contains: Metoprolol 25mg & Chlorthalidone 12.5mg. | 1 Tablet | M/s Lupin Limited | 5.81 | 5.57 |
| 5. | Metoprolol + Chlorthalidone Tablets | Tablet Contains: Metoprolol 50mg & Chlorthalidone 12.5mg. | 1 Tablet | M/s Lupin Limited | 7.22 | 6.92 |
| 6. | Metoprolol + Chlorthalidone Tablets | Tablet Contains: Metoprolol 50mg & Chlorthalidone 12.5mg | 1 Tablet | M/s Lupin Limited | 7.22 | 6.92 |
| 7. | Moxifloxacin+ Cefixime Tablets | Tablets contains: Moxifloxacin 400mg & Cefixime 400mg | 1 Tablet | M/s Lupin Limited | 34.46 | 33.05 |
| 8. | Gliclazide + Pioglitazone + Metformin Tablets | Tablet containing: Gliclazide 60mg, Pioglitazone 7.5mg & Metformin 500mg. | 1 Tablet | M/s Eris Life Sciences Ltd. | 6.25 | 5.99 |
| 9. | Teneligliptin + Metformin Tablets | Tablet Contains: Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg, Metformin HCl 1000mg. | 1 Tablet | M/s Eris Life Sciences Ltd. | 11.33 | 10.87 |
| 10. | Teneligliptin + Metformin Tablets | Tablet Contains: Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg Metformin HCl 500mg. | 1 Tablet | M/s Eris Life Sciences Ltd. | 10.03 | 9.62 |
| 11. | Glimepiride + Metformin Tablets | Tablet containing: Glimepiride 1mg & Metformin 1000mg. | 1 Tablet | M/s Eris Life Sciences Ltd. | 5.93 | 5.69 |
| 12. | Glimepiride + Metformin Tablets | Tablet containing: Glimepiride 2mg & Metformin 1000mg. | 1 Tablet | M/s Eris Life Sciences Ltd. | 7.50 | 7.19 |
| 13. | Glimepiride + Metformin Tablets | Tablet containing: Glimepiride 3mg & Metformin 1000mg. | 1 Tablet | M/s Eris Life Sciences Ltd. | 8.73 | 8.37 |
| 14. | Metformin + Glimepiride + Pioglitazone Tablets | Tablet containing: Metformin 500mg, Glimepiride 1mg & Pioglitazone 15mg. | 1 Tablet | Manufacturer by M/s Jubilant Life Sciences Ltd. and marketed by M/s Hetro Labs Ltd | 2.23 | 2.14 |
| 15. | Metformin + Glimepiride + Pioglitazone Tablets | Tablet containing: Metformin 500mg, Glimepiride 2mg & Pioglitazone 15mg. | 1 Tablet | M/s Biochem Pharmaceuticals Industries Ltd. | 2.45 | 2.35 |
Below are the attachments for the same.
http://www.nppaindia.nic.in/ceiling/press20dec17/Prices(12).pdf
http://www.nppaindia.nic.in/ceiling/press20dec17/Prices(15).pdf
Medical Dialogues had earlier reported that NPPA had notified prices of 65 essential formulations, including those used for the treatment of diabetes, infections, pain and high blood pressure.
Read also: NPPA notifies prices of 65 essential formulations
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd